Bioreactors Market: Current Analysis and Forecast (2021-2027)

Emphasis on Material Type (Glass, Stainless Steel, Single-Use); Control Type (Manual, Automated); Usage (Lab-Scale Production, Pilot Scale Production, Full-Scale Production); End-Users (R&D Departments & Institutes, CROs (Contract Research Organizations), Biopharmaceuticals Companies & Manufacturers, CMOs (Contract Manufacturing Organizations)); and Region/Country

Geography:

Global

Industry:

Healthcare

Last updated:

Jul 2022

bioreactor market
bioreactor market

REQUEST FREE SAMPLE PDF


The bioreactor market is expected to register a CAGR of around 7% over the period of 2021-2027. A bioreactor is defined as a manufactured device or vessel in which a biological reaction is carried out and used to grow a variety of organisms such as yeast, bacteria, and animal cells in the appropriate environment. They form a sustainable environment for cell growth and product formation. Bioreactors are used in the pharmaceutical and biotechnology industries to produce vaccines, antibodies, or biological products. They are also used in industrial processes for culturing organisms under controlled conditions and producing medicines for the treatment of chronic diseases. The growing adoption of a bioreactor can be attributed to the rising prevalence of various chronic diseases such as cardiovascular diseases, cancer, and diabetes coupled with a rapidly growing geriatric population which will increase the demand for therapeutics. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderlies is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Furthermore, the bioreactor market is anticipated to grow on account of the growing technological advancement, and demand for enhancing lab efficiency.


BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, Thermo Fisher Scientific, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with advanced bioreactors.


Insights Presented in the Report


“Amongst Material Type, the single-use category accounted for the majority share in the market in 2020”


Based on material type, the market is classified into glass, stainless steel, and single-use. Amongst material types, the single-use category accounted for a significant share of the market owing to the advantages offered by these types of bioreactors such as the reduced need for cleaning and sterilization, and reduced risk of cross-contamination. Further, the adoption of single-use technologies is also due to its additional benefits such as proper mixing of cells, efficiency in air and gas transfer, and flexible operating conditions to enhance outcomes.


REQUEST FOR CUSTOMIZATION


“Among Control Type, the automated is expected to witness highest CAGR during the forecast period”


Based on control type, the market is categorized into manual and automated. Among these, the automated segment is expected to witness the highest CAGR during the forecast period. The growing preference for mass flow controllers among the end-users has led to the use of automated control types. They are used to ensure additional safety and reduce the operating costs of the bioreactor.


“Amongst Usage, the pilot-scale production category accounted for the majority share in the market in 2020”


Based on usage, the market is classified into lab-scale production, pilot-scale production, and full-scale production. Amongst usage, the pilot-scale production category accounted for a significant share in the market due to development in the pharmaceutical and biotechnology industry, the surge in adoption of cell culture techniques, advancement in R&D activities for the production of personalized medicine, and an increase in the number of clinical and pre-clinical trial studies.


“Amongst End-User, the R&D department and institutes category accounted for the majority share in the market in 2020”


Based on end-users, the market is classified into R&D departments and institutes, CROs (contract research organizations), biopharmaceuticals companies and manufacturing, and CMOS (contract manufacturing organizations). Amongst end-users, the R&D department and institutes category accounted for a significant share in the market due to the development of novel & innovative systems, and the increasing adoption of advanced technologies to ease complex manufacturing. In addition, the expanding biopharmaceutical spending in developing countries will further boost product demand.


SPEAK TO ANALYST


“North America to witness significant growth during the forecast period”


For a better understanding of the market dynamics of the bioreactor market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the bioreactor market industry in 2020 owing to an increase in the number of biomanufacturing facilities and huge investments in the biologics sector.


Reasons to buy this report:



  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

  • The report presents a quick review of overall industry performance at one glance.

  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

  • The study comprehensively covers the market across different segments.

  • Deep dive regional level analysis of the industry.



Customization Options:


Global bioreactor market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.


Table of Contents

Analyzing the historical market, estimation of the current market, and forecasting the future market of the global bioreactor market were the three major steps undertaken to create and analyze the adoption of bioreactors in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global bioreactor market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:


Seek More Details About Research Methodology


Analysis of Historical Market Size


Step 1: In-Depth Study of Secondary Sources:


Detail secondary study was conducted to obtain the historical market size of the bioreactor market through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.


Step 2: Market Segmentation:


After obtaining the historical market size of the bioreactor market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as material type, control type, usage, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.


Step 3: Factor Analysis:


After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the bioreactor market. Further, we conducted factor analysis using dependent and independent variables such as various material type, control type, usage, and end-users of digital pathology. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the bioreactor market sector across the globe.


REQUEST FOR CUSTOMIZATION


Current Market Size Estimate & Forecast


Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global bioreactor market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.


Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:



  • The industry’s market size, in terms of revenue (USD) and the adoption rate of bioreactor market across the major markets domestically

  • All percentage shares, splits, and breakdowns of market segments and sub-segments

  • Key players in the global bioreactor market in terms of solutions offered. Also, the growth strategies adopted by these players to compete in the fast-growing market



Market Size and Share Validation


Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.


Split of Primary Participants in Different Regions


bioreactor market
bioreactor market

SPEAK TO ANALYST


Market Engineering


Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the global bioreactor market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of material type, control type, usage, and end-users in the global bioreactor market.


The main objective of the Global Bioreactor Market Study


The current & future market trends of global bioreactor market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:



  • Analyze the current and forecast market size of the bioreactor market in terms of Value (USD). Also, analyze the current and forecast market size of different segments and sub-segments

  • Segments in the study include areas of material type, control type, usage, and end-users.

  • Define and analysis of the regulatory framework for the bioreactor market industry.

  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.

  • Analyze the current and forecast market size of the bioreactor market for the major region.

  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and Rest of the world.

  • Company profiles of the Bioreactor market and the growth strategies adopted by the market players to sustain in the fast-growing market

  • Deep dive regional level analysis of the industry



Related Reports

Customers who bought this item also bought

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Age Group (Senior Citizens, Adults, and Minors); Distribution channel (Direct Sales, Brokers/Agents, Banks, and Others); and Region/Country

June 20, 2024

India Catheter Market: Current Analysis and Forecast (2024-2032)

India Catheter Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, and Specialty Catheters); Material Type (Silicone, Polyurethane, Latex, and Others); Region

November 4, 2024

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Manual, Automated), Usage Type (Reusable, Disposable), End-user (Hospitals, Home and Others); and Region/Country

October 16, 2024

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country

October 8, 2024